Pediatric REPlAcement of the PulmonaRy ValvE in Tetralogy of Fallot -
NCT03634072 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2023-10-06
Summary
Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect with the vast majority of survivors of corrective surgery left with some degree of right ventricular (RV) volume overload due to pulmonary regurgitation (PR) which cause RV enlargement with right heart failure, diminished biventricular function, ventricular arrhythmia, sudden death and decreased exercise performance over time. Pulmonary valve replacement (PVR) has been thought to ameliorate these complications but the timing of replacement has yet to be determined with equipoise at the moment in this decision making process. As nearly all studies in this regard are retrospective with much less data in pediatric TOF than adults, this pilot trial sets the stage to create a prospective randomized trial in the teenage years.
Conditions
- Tetralogy of Fallot
Interventions
- PROCEDURE
-
PVR
Subjects will undergo PVR via surgery or cardiac catheterization. PVR using cardiac catheterization may require a much shorter hospital stay than traditional heart surgery. If the valve is repaired by surgery, this will require open heart surgery to directly implant a pulmonary valve
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Children's Hospital of Philadelphia
lead OTHER
Principal Investigators
-
Mark Fogel, MD · The Childrens Hospital of Philadelphia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 13 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-06
- Primary Completion
- 2021-01-16
- Completion
- 2021-01-16
Countries
- United States
Study Locations
More Related Trials
-
Allogeneic Left Atrial and Pulmonary Vein Transplant for Pulmonary Vein Stenosis
NCT03456193 ·Status: SUSPENDED ·Phase: NA
-
Follow Up on Freestyle Valves in Children
NCT00385112 ·Status: COMPLETED
-
Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
NCT03632967 ·Status: TERMINATED ·Phase: NA
-
Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation
NCT07140562 ·Status: RECRUITING ·Phase: NA
-
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
NCT04100720 ·Status: WITHDRAWN ·Phase: NA
-
A Feasibility Study to Evaluate the Safety and Short-term Effectiveness of Transcatheter Pulmonary Valve (TPV)
NCT02555319 ·Status: COMPLETED ·Phase: NA
-
Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)
NCT01762124 ·Status: COMPLETED ·Phase: NA
-
Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD
NCT04458103 ·Status: TERMINATED ·Phase: NA
-
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
NCT03983512 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort
NCT00740870 ·Status: COMPLETED ·Phase: NA
-
Xeltis Pulmonary Valved Conduit Safety and Performance Study
NCT03405636 ·Status: WITHDRAWN ·Phase: NA
-
TRICuspid Intervention in Heart Failure Trial
NCT04634266 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A First in Human Study for the Versa Device for Tricuspid Regurgitation
NCT06368401 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery
NCT01034007 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Venus P-valve to Treat RVOT Stenosis With Pulmonary Regurgitation
NCT02071654 ·Status: UNKNOWN ·Phase: PHASE3
-
Early Phase Study Using the 'Pivot Extend' System as a Treatment for Patients With Tricuspid Regurgitation
NCT07172477 ·Status: RECRUITING ·Phase: NA
-
PV Loop & Coarctation Study
NCT05362721 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI
NCT01018355 ·Status: TERMINATED ·Phase: NA
-
Transcatheter Pulmonary Valve Implantation With SAPIEN 3 Valve
NCT05264181 ·Status: UNKNOWN
-
Patent Foramen Ovale (PFO) Closure at the Time of Endovascular Cardiac Electronic Device Implantation
NCT03232450 ·Status: WITHDRAWN ·Phase: NA
-
Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study
NCT03022708 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts
NCT02846753 ·Status: UNKNOWN ·Phase: NA
-
VenusP-Valve Pivotal Study (PROTEUS STUDY)
NCT06010563 ·Status: RECRUITING ·Phase: NA
-
Early Feasibility EXperience of Posterior Leaflet RestOration to REduce Mitral Regurgitation
NCT04098328 ·Status: TERMINATED
-
Study to Assess Safety of the Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract Reconstruction
NCT02700100 ·Status: UNKNOWN ·Phase: NA